Rare Cancers: Improving Diagnosis and Prognosis Through Collaborative Research
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Diagnosis and Prognosis".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 12
Special Issue Editor
Special Issue Information
Dear Colleagues,
Rare cancers present unique challenges due to their low incidence, limited research, and often delayed or inaccurate diagnoses. This Special Issue emphasizes the critical role of multidisciplinary collaboration in enhancing our understanding, detection, and management of rare malignancies. By integrating cutting-edge research, innovative diagnostic tools, and shared clinical insights, it seeks to address unmet needs in the treatment of rare cancers. Topics include novel biomarkers, precision medicine approaches, patient-centered outcomes, and global data sharing that can improve prognostic accuracy and treatment strategies. The contributions of clinicians and researchers are of great significance in overcoming the limitations imposed by small patient populations. This Special Issue aims to promote efforts to combat rare cancers by fostering scientific dialog, improving early detection, and optimizing personalized treatment to ensure optimal patient outcomes.
Dr. Chen-Wang Chang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- rare cancer
- diagnosis and prognosis
- biomarker
- early detection
- precision medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
